Two Sigma Advisers LP Sells 8,500 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
Two Sigma Advisers LP decreased its stake in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 7.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 106,600 shares of the company’s stock after selling 8,500 shares during the period. […]
